Published in Pharmacopsychiatry on November 01, 2000
Obsessive-compulsive disorder with bipolar diathesis following isotretinoin therapy remitting upon treatment with olanzapine and fluvoxamine. Neuropsychiatr Dis Treat (2010) 0.87
The 5-HT7 receptor influences stereotypic behavior in a model of obsessive-compulsive disorder. Neurosci Lett (2007) 0.83
Drug Induced Obsessive Compulsive Disorder in Schizophrenia. Med J Armed Forces India (2011) 0.75
The Global Adherence Project (GAP): a multicenter observational study on adherence to disease-modifying therapies in patients with relapsing-remitting multiple sclerosis. Eur J Neurol (2011) 2.90
Obstructive sleep apnea is associated with fatigue in multiple sclerosis. Mult Scler (2011) 2.77
Once-daily venlafaxine extended release (XR) compared with fluoxetine in outpatients with depression and anxiety. Venlafaxine XR 360 Study Group. J Clin Psychiatry (1999) 1.64
Kinetic basis for insensitivity to tetrodotoxin and saxitoxin in sodium channels of canine heart and denervated rat skeletal muscle. Biochemistry (1987) 1.60
An emerging pharmacology of peptide toxins targeted against potassium channels. J Membr Biol (1988) 1.59
Zn2(+)-induced subconductance events in cardiac Na+ channels prolonged by batrachotoxin. Current-voltage behavior and single-channel kinetics. J Gen Physiol (1991) 1.31
Reliability, validity, and applicability of the Quebec User Evaluation of Satisfaction with assistive Technology (QUEST 2.0) for adults with multiple sclerosis. Disabil Rehabil (2002) 1.22
Impact of sleep disorder treatment on fatigue in multiple sclerosis. Mult Scler (2012) 1.18
Analysis of the blocking activity of charybdotoxin homologs and iodinated derivatives against Ca2+-activated K+ channels. J Membr Biol (1989) 1.16
Fatigue in multiple sclerosis: association with disease-related, behavioural and psychosocial factors. Mult Scler (2007) 1.06
Choline is increased in pre-lesional normal appearing white matter in multiple sclerosis. J Neurol (2002) 1.06
Functional brain reorganization for hand movement in patients with multiple sclerosis: defining distinct effects of injury and disability. Brain (2002) 1.05
Noradrenergic axon terminals in the cerebral cortex of rat. III. Topometric ultrastructural analysis. Brain Res (1977) 1.02
Serotonergic markers in platelets of patients with major depression: upregulation of 5-HT2 receptors. J Psychiatry Neurosci (1995) 0.97
Role of phosphorylation in desensitization of acetylcholine receptors expressed in Xenopus oocytes. J Neurosci (1994) 0.95
Involvement of nitric oxide in neurodegeneration: a study on the experimental models of Parkinson's disease. Redox Rep (2005) 0.92
Effects of selective serotonin reuptake inhibitors on platelet serotonin parameters in major depressive disorder. Biol Psychiatry (1997) 0.92
Noradrenergic axon terminals in the cerebral cortex of rat. II. Quantitative data revealed by light and electron microscope radioautography of the frontal cortex. Brain Res (1973) 0.90
Multiple sclerosis of the spinal cord: diagnosis and follow-up with contrast-enhanced MR and correlation with clinical activity. AJNR Am J Neuroradiol (1998) 0.90
Varicella-zoster virus DNA in CSF and arteries in delayed contralateral hemiplegia: evidence for viral invasion of cerebral arteries. Neurology (1996) 0.89
Hypothalamic pathology in the neuroleptic malignant syndrome. Am J Psychiatry (1988) 0.88
Celastrus paniculatus seed oil and organic extracts attenuate hydrogen peroxide- and glutamate-induced injury in embryonic rat forebrain neuronal cells. Phytomedicine (2005) 0.87
Altered naive CD4 and CD8 T cell homeostasis in patients with relapsing-remitting multiple sclerosis: thymic versus peripheral (non-thymic) mechanisms. Clin Exp Immunol (2006) 0.87
Platelet serotonergic indices in major depression: up-regulation of 5-HT2A receptors unchanged by antidepressant treatment. Psychiatry Res (1997) 0.87
Heterogeneity on familial hyperlipoproteinemia type II on the basis of fasting plasma triglyceride-cholesterol ratio and plasma cholesterol response to ethyl p-chlorophenoxyisobutyrate. Rev Can Biol (1971) 0.85
Alcohol withdrawal concealing symptoms of subdural hematoma--a caveat. Psychiatr J Univ Ott (1990) 0.85
Characterization of recombinant GABAA receptors produced in transfected cells from murine alpha 1, beta 1, and gamma 2 subunit cDNAs. Neurosci Lett (1991) 0.85
Upregulation of TRAIL expression on human T lymphocytes by interferon beta and glatiramer acetate. Mult Scler (2005) 0.84
Two-tone suppression in auditory nerve of the cat: rate-intensity and temporal analyses. J Acoust Soc Am (1978) 0.82
Manic psychosis associated with procarbazine. Br Med J (Clin Res Ed) (1982) 0.82
Clinical sub-groups of multiple sclerosis in relation to HLA: DR alleles as possible markers of disease progression. Can J Neurol Sci (1985) 0.81
A Canadian multicenter, double-blind study of paroxetine and fluoxetine in major depressive disorder. J Affect Disord (1999) 0.81
Genetic susceptibility to MS: a second stage analysis in Canadian MS families. Neurogenetics (2001) 0.80
Multiple saxitoxin-binding sites in bullfrog muscle: tetrodotoxin-sensitive sodium channels and tetrodotoxin-insensitive sites of unknown function. Mol Pharmacol (1988) 0.80
Evidence for the role of brain biogenic amines in depressed motor activity seen in chemically thyroidectomized rats. J Neurochem (1976) 0.80
The patterns of mental disorder in Jewish and non-Jewish admissions to a district general hospital psychiatric unit: is manic-depressive illness a typically Jewish disorder? Psychol Med (1983) 0.79
Sertraline in generalized anxiety disorder: efficacy in treating the psychic and somatic anxiety factors. Acta Psychiatr Scand (2005) 0.79
Event-related potentials and selective attention in major depressive illness. J Affect Disord (1991) 0.79
Manic-like response to phototherapy. Can J Psychiatry (1991) 0.78
Interpreting therapeutic effect in multiple sclerosis via MRI contrast enhancing lesions: now you see them, now you don't. J Neurol (2014) 0.78
Placebos in clinical trials of psychotropic medication. Can J Psychiatry (1997) 0.78
Turner syndrome diagnosed in northeastern Malaysia. Singapore Med J (2008) 0.77
A clinical and immunological study of the effects of transfer factor on multiple sclerosis patients. Clin Exp Immunol (1981) 0.77
Synthesis and characterization of an aryl-azidoparoxetine. A novel photo-affinity probe for serotonin-transporter. Biochem Pharmacol (1995) 0.77
HLA antigens-linked genetic control in multiple sclerosis patients resistant and susceptible to infection. J Neurol (1983) 0.77
Determination of the optimal concentration of lithium for the prophylaxis of manic-depressive disorder. Biol Psychiatry (1982) 0.76
Comparative tolerance of IFN beta-1a regimens in patients with relapsing multiple sclerosis. The EVIDENCE study. J Neurol (2005) 0.76
Thiamine, riboflavin and pyridoxine deficiency in psychiatric in-patients. Br J Psychiatry (1982) 0.75
Systemic lupus erythematosus presenting as morbid jealousy. Postgrad Med J (1980) 0.75
A time series aggregation model for predicting the incidence of syphilis. Sex Transm Dis (1979) 0.75
Dysthymia and serotonin. Int Clin Psychopharmacol (1993) 0.75
Noradrenergic axon in the cerebral cortex of rat. I. Radioautographic visualization after topical application of DL-( 3 H)norepinephrine. Brain Res (1973) 0.75
A double-blind placebo-controlled comparison of moclobemide and amitriptyline in the treatment of depression. Can J Psychiatry (1992) 0.75
Jack fruit lectin binding pattern in carcinoma of the uterine cervix. J Exp Pathol (1990) 0.75
Alternating electrical-resistance changes in the guinea-pig cochlea caused by acoustic stimuli. J Acoust Soc Am (1977) 0.75
Association of ethnicity with antipsychotic dosage using STRUCTURE analysis. Pharmacopsychiatry (2013) 0.75
Past infectious events and disease evolution in multiple sclerosis. J Neurol (1983) 0.75
Erythrocyte lithium transport variables as a marker for manic-depressive disorder. Neuropsychobiology (1983) 0.75
Emphysematous urinoma in a renal transplant patient. Am J Kidney Dis (2001) 0.75
Psychopharmacological treatment response of patients with a DSM-III diagnosis of dysthymic disorder. Psychopharmacol Bull (1994) 0.75
A linkage study of primary affective disorder. Br J Psychiatry (1988) 0.75
Demonstration of a tumour associated antigen in human oral cancers. Indian J Med Res (1981) 0.75
Efficacy of ACTH 4-9 analog, methylphenidate, and placebo on attention deficit disorder with hyperkinesis. Prog Neuropsychopharmacol Biol Psychiatry (1984) 0.75
Motor paralytic bladder. J Assoc Physicians India (1986) 0.75
A comparative study of the efficacy of ACTH4-9 analog, methylphenidate, and placebo on attention deficit disorder with hyperkinesis. J Clin Psychopharmacol (1983) 0.75
Neurophysiological correlates of sibling pairs discordant for bipolar affective disorder. Am J Psychiatry (1985) 0.75
Effects of antidepressants on thinking styles in depressed inpatients. Prog Neuropsychopharmacol Biol Psychiatry (1988) 0.75
[Acute intentional normovolemic hemodilution. The value of plasma autotransfusion in maxillofacial surgery]. Cah Anesthesiol (1990) 0.75
Behavioural reactions to triazolam. Lancet (1979) 0.75
Distribution of U antigen among West Indians. Transfusion (1983) 0.75